| Application no. and date | 15175258.1 (espacenet) (Federated) (European Patent Register), 20100611 | | Patent/reg. no. and date | DK/EP 2952191, 20180822 | | Publication date | 20151209 | | Priority no. and date | US 186445 P, 20090612 | | EP pub. no. and date |
EP 2952191 20151209 | | Effective date | | | Applicant/owner | Sunovion Pharmaceuticals Inc., 84 Waterford Drive
Marlborough, MA 01752, US | | Applicant ref. no. | P5142DKEP | | Inventor | Giovinazzo, Anthony John, 1302 Kestell Blvd.
Oakville, Ontario L6H 0B9, CA,
Bryson, Nathan John, 99 Glen Rd., Apt. 1
Toronto, Ontario M4W 2V8, CA,
de Somer, Marc L., 4 Upland Road
Winchester, Massachusetts 01890, US,
Hedden, David Bruce, 2483 Dundee Drive
Ann Arbor, MI 48103, US | | Representative | HØIBERG P/S, Adelgade 12, 1304 København K | | Opponent | | | IPC Class | A01N 43/42 (2006.01) , A61K 31/44 (2006.01) , A61K 31/473 (2006.01) , A61K 47/02 (2006.01) , A61P 15/10 (2006.01) , A61P 25/16 (2006.01) | | Title | Sublingual apomorfin | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
